Financial Industry News September 26th News This evening, I will take a look at the important announcements tonight - Top Group plans to invest 3 billion yuan to build a new energy vehicle core parts production base, Tongxing Environmental Protection receives a letter of concern: It is required to verify whether there is a situation of cooperating with shareholders' reduction of holdings, and FB2001 for cutting-edge bioatomization and inhalation obtained a drug clinical trial approval notice...
[Major matters]
Jiuguijiu: The company's management plans to increase its holdings of shares by no less than 6.2 million yuan
Jiuguijiu (000799) announced on the evening of September 26th that the company's chairman Wang Hao, vice chairman and general manager Zheng Yi and other management plan to increase their holdings of the company's shares by no less than 6.2 million yuan within 2 months.
Shenzhen Xinxing: It plans to invest 550 million yuan in aluminum alloy foil material blanks for lithium batteries
Shenzhen Xinxing (603978) announced on the evening of September 26 that the wholly-owned subsidiary Luoyang Xinxing plans to invest 550 million yuan to use the existing factory in Luoyang Xinxing’s existing factory in Yanshi District, Henan Province to build a production project for aluminum alloy foil material blanks for lithium batteries with an annual output of 100,000 tons. The construction period is 2 years.
Top Group: It plans to invest 3 billion yuan in the construction of a core parts production base for new energy vehicles
Top Group (601689) announced on the evening of September 26 that the company and the Xi'an Economic and Technological Development Zone Management Committee signed the "Agreement for the Entry of Auto Parts Production Projects", intending to invest about 3 billion yuan in Xi'an Economic and Technological Development Zone , with a planned land scale of about 400 mu, and build a core component production base for new energy vehicles, mainly producing core modules and system components of new energy vehicles, including lightweight chassis, internal and external functional parts, intelligent brake systems, intelligent steering systems, etc. The project is implemented in three phases.
step length pharmaceutical: Obtained the registration certificate for omeprazole sodium for injection
step length pharmaceutical (603858) announced on the evening of September 26 that its wholly-owned subsidiary Shandong Danhong Pharmaceutical obtained the registration certificate for omeprazole sodium for injection. Omeprazole sodium for injection is mainly used for: ① Hemorrhage of peptic ulcer and anastomotic ulcer bleeding; ② Acute gastric mucosa damage caused by stress state, acute gastric mucosa damage caused by nonsteroidal anti-inflammatory drugs, etc.
Frontier Biology: FB2001 for atomized inhalation was approved for drug clinical trials
Frontier Biology (688221) announced on the evening of September 26 that it received the "Notice of Approval for Drug Clinical Trials" approved by National Medical Products Administration . The clinical trial of FB2001 for atomized inhalation was intended to be used to treat mild and common novel coronavirus (SARS-CoV-2) infection and prevention after exposure of novel coronavirus (SARSCoV-2) was approved.
Tongxing Environmental Protection's letter of concern: It is required to verify whether there is any situation of cooperating with shareholders' share reduction
Tongxing Environmental Protection's letter of concern. Previously, the company disclosed that the company and University of Science and Technology of China decided to jointly carry out research on energy storage battery electrode materials such as lithium-ion battery , sodium ion battery, etc. The company's main business includes flue gas treatment engineering services, flue gas treatment product production, etc. Please explain the signing background and main considerations of the above cooperation agreement, whether the relevant cooperation is exclusive, and whether it is in line with the company's main business and development strategy. The company's shareholders Ningbo Luxi Equity Investment Partnership (Limited Partnership) and Anhui Hi-Tech Jintong Anyi Equity Investment Fund (Limited Partnership) have plans to reduce their holdings in the near future. Please check the above shareholders' share reduction since the announcement disclosed, and explain whether there is any situation of cooperating with shareholders' share reduction; whether there is any situation of suspected insider trading.
Iceberg: It is planned to purchase 60% equity of Panasonic Compressor , 55% equity of Panasonic Cold Machinery
Iceberg announced that it plans to purchase 60% stake in Panasonic Compressor held by Sanyo Electric, 30% stake in Panasonic Cold Machinery held by Panasonic China, 25% stake in Panasonic Cold Machinery held by Panasonic Cold Machinery held by Panasonic Cold Machinery held by Panasonic Cold Machinery held by Panasonic Cold Machinery held by Panasonic Cold Machinery. The total price of the target assets of this transaction is 1.01 billion yuan; after the completion of this transaction, the company will directly or indirectly hold 100% stake in Panasonic Compressor and 100% stake in Panasonic Cold Machinery.
ST Chengxing: The wholly-owned subsidiary is affected by power restrictions and will start to reduce production from September 26
ST Chengxing (600078) announced on the evening of September 26 that the production plant of the wholly-owned subsidiary Yunnan Xuanwei Phosphate Electric Co., Ltd. recently received a notice from the local power supply unit on the implementation of energy efficiency management, and will not be able to operate at full capacity and will start to reduce production from September 26, 2022.Xuanwei Factory's net profit in the first half of 2022 accounted for 26.05% of the company's consolidated financial statements. According to the above notice, the time for the full production capacity to be restored cannot be estimated at the moment.
Kelaiying: It plans to invest 4 billion to 5 billion yuan to build a biomedical R&D and production integration base
Kelaiying (002821) announced on the evening of September 26 that the company signed an investment agreement with the Management Committee of Taixing Economic Development Zone, Jiangsu Province on the same day, and plans to invest in the biomedical R&D and production integration base project in Taixing. The project is expected to have a total investment of 4 billion to 5 billion yuan. The project plans will be designed, built in phases, and put into production in batches. The main construction contents include: the research and development and production of small molecule CDMO chemical raw materials and raw materials, as well as the construction of future small molecule CDMO drug preparations, drug research and development, and new technology promotion and application.
[Mergers and Acquisitions]
Boqian New Materials: It plans to raise no more than 828 million yuan from the actual controller of the company to raise no more than 828 million yuan from the actual controller of the company to raise no more than 828 million yuan from the actual controller of the company to raise no more than 828 million yuan from the actual controller of the company to supplement working capital or repay bank debts.
Guoxin Health: The planned increase will raise no more than 794 million yuan. The subsidiaries of the actual controller participated in the subscription of
Guoxin Health (000503) announced on the evening of September 26 that the company plans to issue shares to no more than 35 specific objects, including Guoxin Development, to raise no more than 794 million yuan, and to invest in the construction of the three medical digital service system, the integrated construction of health services, the construction of commercial insurance data service platform, the R&D center upgrade construction project, and the marketing network upgrade construction project. Among them, the number of shares that Guoxin Development plans to subscribe is not less than 25.98% of the issuance quantity and not more than 40% of the issuance quantity. China Guoxin is the actual controller of the company and directly holds 100% of Guoxin Development's shares.
Yunda Co., Ltd. : The application for public issuance of convertible bonds was approved by
Yunda Co., Ltd. (002120) announced on the evening of September 26 that the application for public issuance of convertible corporate bonds was approved by the China Securities Regulatory Commission’s Issuance and Review Committee.
Igor: Application for private placement of shares was approved and passed
Igor (002922) announced on the evening of September 26 that the company's application for private placement of shares was approved by the China Securities Regulatory Commission's Issuance and Review Committee.
Lan Dai Technology: The application for private placement of shares was approved by
Lan Dai Technology (002765) announced on the evening of September 26 that the company's application for private placement of shares was approved by the China Securities Regulatory Commission's Issuance and Review Committee.
Zhengzhou Bank : Issuance of financial bonds not exceeding 10 billion yuan was approved by the central bank
Zhengzhou Bank (002936) announced on the evening of September 26 that it recently received the "Decision on Approving Administrative License" by the People's Bank of China, agreeing that the bank will issue financial bonds not exceeding 10 billion yuan in the national interbank bond market.
Donghua Technology: Application for private placement of shares was approved and approved
Donghua Technology (002140) announced on the evening of September 26 that the company's application for private placement of shares was approved by the China Securities Regulatory Commission's Issuance and Review Committee.
Dongcai Technology: The application for public issuance of convertible bonds was approved by
Dongcai Technology (601208) announced on the evening of September 26 that the application for public issuance of convertible bonds was approved by the China Securities Regulatory Commission’s Issuance and Review Committee.
[Increase and reduce holdings]
Ruifeng Bank: Some supervisors and other managers voluntarily increase their holdings of shares
Ruifeng Bank (601528) announced on the evening of September 26 that the bank's two supervisors and 45 other managers plan to increase their holdings by no less than 12 million yuan through centralized bidding transactions within 3 months. This share increase plan does not have a price range.
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
Eddie Precision : The controlling shareholder plans to increase his holdings of the company's shares by 50 million to 100 million
Eddie Precision (603638) announced on the evening of September 26 that the company's controlling shareholder, actual controller, chairman and general manager Song Fei plans to increase his holdings of the company's shares within 6 months, with a total increase of no less than 50 million yuan and no more than 100 million yuan.
Ruo Yuchen: Langzi shares intends to reduce their holdings of the company by no more than 6%
Ruo Yuchen (003010) announced on the evening of September 26 that Langzi shares, a shareholder holding 12.33% of the shares, plans to reduce their holdings of the company by no more than 7.302 million shares (accounting for approximately 6% of the company's total share capital) through centralized bidding and/or bulk transactions.
Haitian Shares: Hebang Group plans to reduce the holdings of the company's shares by no more than 6%
Haitian Shares (603759) announced on the evening of September 26 that shareholders holding 9.62% Sichuan Hebang Investment Group Co., Ltd. (referred to as "Hebang Group") plans to reduce the holdings of the company's shares by no more than 27.7056 million shares (accounting for 6% of the company's total share capital).
Huazhong CNC : Huake Asset plans to reduce its holdings of the company by no more than 4%
Huazhong CNC (300161) announced on the evening of September 26 that Wuhan Huazhong University of Science and Technology Asset Management Co., Ltd. (hereinafter referred to as "Huake Asset"), a shareholder of the company, plans to reduce its holdings of the company by no more than 7.9478 million shares (accounting for 4% of the company's total share capital) through centralized bidding and bulk transactions.
Baosteel Packaging : Changxia Jinshi and its joint actors plan to reduce their holdings by no more than 4.86% of the shares
Baosteel Packaging (601968) announced on the evening of September 26 that Changxia Jinshi (Wuhan) Equity Investment Fund Partnership (Limited Partnership) (referred to as "Changxia Jinshi") and its joint actor Anhui Jiaokong Jinshi M&A Fund Partnership (Limited Partnership) plan to reduce their holdings by no more than 4.86% of the shares of the company.
China Gold : CITIC Securities Investment plans to reduce its holdings of the company's shares by no more than 2%
China Gold (600916) announced on the evening of September 26 that CITIC Securities Investment Co., Ltd., a shareholder holding 4.23% of the shares, plans to reduce its holdings of the company's shares by no more than 2%, that is, no more than 33.6 million shares. CITIC Securities Co., Ltd. is the controlling shareholder of CITIC Securities Investment.
Daily Interaction: Dinglu Zhongyuan plans to reduce its holdings of the company by no more than 2.94%
Daily Interaction (300766) announced on the evening of September 26 that Beijing Dinglu Zhongyuan Technology Co., Ltd., which holds 9.81% of the shares, plans to reduce its holdings of the company by no more than 2.94%. In addition, Hangzhou Wogetu Investment Management Partnership (Limited Partnership), the equity incentive holding platform for the company's backbone employees before listing, decided to terminate the share reduction plan disclosed in April this year in advance. In the range of the reduction plan, it did not reduce its holdings of the company's shares.
ST Haiyue: It plans to sell its shares of Huakang shares at an opportunity
ST Haiyue (600387) on the evening of September 26, and plans to reduce its holdings of Huakang shares currently held by the company through centralized bidding transactions or bulk transactions. Currently, the company holds 3.9131 million shares of Huakang Co., Ltd., accounting for 1.71% of its total share capital.
[Real Performance Express]
Basmey : Net profit in the first three quarters is expected to increase by 141.36%-169.92% year-on-year
Basmey (300796) released its performance forecast on the evening of September 26, with net profit expected to increase by 106 million yuan to 119 million yuan in the first three quarters, a year-on-year increase of 141.36%-169.92%, of which the net profit in the third quarter is expected to increase by 379.26%-570.96%. The company focuses on environmentally friendly pesticides and intermediates businesses, and continues to explore new high-quality customers such as BASF, a leading international agrochemical company; the sales pricing of main products has been improved.
[Other matters]
Shanghai Pharmaceutical : The holding subsidiary warfarin sodium tablets passed the generic drug consistency evaluation
Shanghai Pharmaceutical (601607) announced on the evening of September 26 that the holding subsidiary warfarin sodium tablets passed the generic drug consistency evaluation. Warfarin sodium tablets are mainly used for the prevention and treatment of thromboembolic complications after deep venous thrombosis (DVT) and pulmonary embolism (PE), atrial fibrillation (AF) and/or heart valve replacement, reducing the risk of death, recurrence, and thromboembolic events after myocardial infarction (such as stroke or systemic embolism).
Xusheng Co., Ltd.: The holding subsidiary received a designated notice for customer projects
Xusheng Co., Ltd. (603305) announced on the evening of September 26 that the holding subsidiary Ningbo Hesheng Aluminum Bottle Technology Co., Ltd. recently received a designated notice for development from importers and distributors of a European catering equipment, cream chargers and other products, and selected Hesheng Aluminum Bottle as the designated supplier of its aluminum bottles. According to customer planning, the total annualized sales amount of this designated project is about 800 million yuan, and it is expected to gradually start mass production in the fourth quarter of 2022.
Delinhai: It plans to invest 200 million yuan to establish a biomass new energy subsidiary
Delinhai (688069) announced on the evening of September 26 that the company plans to set up a wholly-owned subsidiary in Wuxi for 200 million yuan. The wholly-owned subsidiary after its establishment mainly develops and utilizes the biomass resources formed by the management of the company's eutrophication lake reservoir to produce biomass forming fuel (BMF). BMF is a clean and low-carbon renewable energy, and is a high-quality environmentally friendly fuel that replaces fossil energy such as coal, natural gas, , etc.
Saisheng Pharmaceutical : Received the application for supplementary application for humanized anti-VEGF monoclonal antibody injection
Saisheng Pharmaceutical (300485) announced on the evening of September 26 that the company received the application for supplementary application for humanized anti-VEGF monoclonal antibody injection, marking that the supplementary application for major changes involved in the pharmaceutical changes of this variety has entered the review stage. The indication of this drug is metastatic colorectal cancer, etc. The project is currently in the Phase I clinical research stage.
Chuling Information : Winning the bid for China Mobile's miniaturized access PTN equipment centralized procurement project
Chuling Information (300250) announced on the evening of September 26 that the company won the bid for China Mobile's miniaturized access PTN equipment centralized procurement project from 2022 to 2023, with a winning share of 20%. According to the total number of bids of 174,600, the winning bid is about 34,920, and the estimated amount is 16 million yuan. The specific amount is subject to the winning notice or the final framework contract.
hua Guang Energy: Signed a general contract for boiler project of 146 million yuan
hua Guang Energy (600475) announced on the evening of September 26 that recently, the company's holding subsidiary Huaguang (Xi'an) Design Institute and Shaanxi Runzhong Clean Energy Co., Ltd. signed the "General contract for the project of Shaanxi Runzhong Clean Energy Co., Ltd. to build a 280t/h backup coal powder boiler project", with a total contract price of 146 million yuan and the performance period of contract 6540 days.
Fuchun Dyeing and Weaving: It is planned to carry out futures hedging business without exceeding 50 million yuan
Fuchun Dyeing and Weaving (605189) announced on the evening of September 26 that the company and its subsidiaries intend to carry out futures hedging business. The transaction types are limited to raw materials related to the company's production and operation, including but not limited to cotton and cotton yarn. The total margin for the company's futures hedging business shall not exceed 50 million yuan. The company conducts futures hedging business to lock in the risk of price fluctuations in raw material , and does not engage in speculative or arbitrage transactions.
New Open Source: Received a letter of recovery based on the share purchase agreement
New Open Source (300109) announced on the evening of September 26 that the company recently received a letter of "Recovery Letter based on the share purchase agreement" issued by Abcam Plc and Abcam US Group Holdings Inc., based on its understanding of related matters, it filed a claim to seek compensation of no less than US$18 million. The company maintains objections to the "Letter of Recourse" and will actively seek solutions including consultation or arbitration. In the future, if the incident cannot be properly resolved, the company may bear certain compensation liability.
Dongxing Securities: Chairman Wei Qinghua resigned due to age reasons
Dongxing Securities (601198) announced on the evening of September 26 that due to age reasons, the company's chairman Wei Qinghua recently submitted a resignation report on to the board of directors, applying to resign from the company's director, chairman, legal representative of , chairman of the board of directors' development strategy committee, and member of the board of directors' remuneration and nomination committee.
AVIC Shenfei : Subsidiaries and Shenbei New District Government and others signed a strategic cooperation framework agreement
AVIC Shenfei (600760) announced on the evening of September 26 that the wholly-owned subsidiary Shenfei Company and Shenyang Shenbei New District Government and Shenyang Aviation Production Group jointly signed a "Strategic Cooperation Framework Agreement", and the three parties jointly promoted the construction of the first phase of key projects such as the aviation composite material processing center project, the aviation titanium alloy forming and additive processing center project, and the Shenyang Aviation Intelligent Manufacturing Production Base project.
Zhejiang Yongqiang: It plans to set up a joint venture to engage in electric tents and other businesses
Zhejiang Yongqiang (002489) announced on the evening of September 26 that the company plans to jointly invest in the establishment of a company mainly engaged in electric tents and smart sunroom series products with Nanjing Shanneng Energy Saving Technology Co., Ltd. in Ningbo . This investment will help enrich and improve the company's layout in the field of outdoor leisure and home furnishings.
International Industrial : Termination of equity transfer of real estate subsidiaries
International Industrial (000159) announced on the evening of September 26 that the company originally planned to transfer 100% of the equity of its wholly-owned subsidiary Xinjiang International Real Estate Real Estate Development Co., Ltd. and 100% of the equity of its wholly-owned subsidiary Xinjiang Sinochem Real Estate Co., Ltd. to Shaanxi Jiushang Hetai Industrial Co., Ltd. In order to further clarify the rights and responsibilities of both parties and control the risks of transfer implementation, the company proposed a payment plan to adjust the equity transfer price, and the transferee failed to accept the new payment plan proposed by the company. After negotiation, on September 26, the two parties signed the "Termination Agreement" for the equity transfer to terminate the equity transfer.
Jiangsu Bank : Ji Ming resigned as president Ge Renyu will take over as
Jiangsu Bank (600919) announced on the evening of September 26 that, according to the organizational arrangements, Ji Ming applied to resign from the positions of director, president and member of the strategic committee of the Bank, member of the audit committee of the board of directors, and chairman of the board of directors’ risk management committee. The board of directors agreed to nominate Ge Renyu as the candidate for the fifth board of directors of the company and agreed to appoint Ge Renyu as the company's president.
Anyuan Coal Industry: The Shangzhuang Coal Mine belonging to will resume production since September 23
Anyuan Coal Industry (600397) announced on the evening of September 26 that the Fengcheng City Emergency Management Bureau agreed that the Shangzhuang Coal Mine belonging to the company will resume production from the evening shift on September 23. The actual number of days of production suspension of Shangzhuang Coal Mine this time is 180 days, which is expected to affect the company's commercial coal output of 101,000 tons, and an estimated loss of about 43 million yuan.
Xinhua Pharmaceutical : The subsidiary Cefolklo sustained release tablets passed the generic drug consistency evaluation
Xinhua Pharmaceutical (000756) announced on the evening of September 26 that recently, the company's wholly-owned subsidiary Xinda Pharmaceutical received the "Notice of Approval for Drug Supplementary Application" approved by the State Food and Drug Administration. The application for consistency evaluation of this product was approved. Cefaclor sustained release tablets are one of the company's key products, and Xinda Pharmaceutical is the second domestic company to pass consistency evaluation.
Hengrui Medicine : Subsidiary drugs are intended to be included in the priority review procedure
Hengrui Medicine (600276) announced on the evening of September 26 that the drug dexmedetomidine hydrochloride nasal spray of subsidiary Shanghai Hengrui Medicine was planned to be included in the public announcement list of the priority review varieties by the Drug Review Center of the State Food and Drug Administration, with a public announcement period of 7 days. This product is suitable for preoperative sedation in children (such as general anesthesia in children).
Hengyin Technology: The principal of the purchased trust product is RMB 15 million and the remaining investment income is redeemed overdue
Hengyin Technology (603106) announced on the evening of September 26 that the company purchased the "Chang'an Ning-Yingxiang No. 1 Collective Fund Trust Plan" of Chang'an Trust in 2021. The maturity date is September 9, 2022. At present, the company has received a total of RMB 636,700 of the investment income of the product, and the principal of RMB 15 million and the remaining investment income have not been redeemed at maturity. Changan Trust has frozen the non- restricted circulating shares of a listed company held by the debtor, and has completed the execution case in the Pudong New District Court of Shanghai. The case is currently under compulsory execution. Given that there is still uncertainty in the recovery time of this investment fund and based on the nature of non-guaranteed financial products, there is a risk that principal and interest cannot be fully recovered.
Huajian Group: Jointly signed the contract for the construction project of the Yueyang Free Trade Zone Complex
Huajian Group (600629) announced on the evening of September 26 that the subsidiary Shanghai Architectural Design Research Institute Co., Ltd. and Hunan Gangchen Construction Engineering Co., Ltd. and Yueyang Zimao Industrial Investment Co., Ltd. signed the "Yueyang Free Trade Zone Digital Economy Industrial Complex Construction Project Contract", with a total contract amount of 6.025 billion yuan, of which the Shanghai Institute undertakes the design part, accounting for about 0.93%, which is 56.165 million yuan.
Seno Medical: The coronary drug elution stent system has obtained the domestic medical device registration certificate
Seno Medical (688108) announced on the evening of September 26 that the company's coronary drug elution stent system has obtained the domestic medical device registration certificate. This product is mainly used to improve the symptoms of vascular stenosis in patients with ischemic heart disease.
Haixiang Pharmaceutical : It plans to be about 300 million yuan in Taizhou Investment and Construction Headquarters Research Institute
Haixiang Pharmaceutical (002099) announced on the evening of September 26 that in order to further enhance the company's comprehensive R&D capabilities and expand the CDMO rapid response capabilities and the scale of the business of the animal protection sector, the company plans to purchase about 45 acres of industrial land in Haimen Street, Jiaojiang District, Taizhou through its subsidiary. The project is expected to have a total investment of about 300 million yuan and a construction period of 24 months.
Shenma Co., Ltd.: It plans to increase its capital for 173 million yuan for the subsidiary to be used for the annual output of 30,000 tons of BOPA film project
Shenma Co., Ltd. (600810) announced on the evening of September 26 that the company plans to increase its capital for 173 million yuan in cash to its wholly-owned subsidiary Henan Pingmei Shenma Nylon Materials (Suiping) Co., Ltd. for the annual output of 30,000 tons of BOPA film. After the implementation of the BOPA film project planned to be invested and constructed this time, Pingmei Shenma Nylon Materials (Suiping) Co., Ltd. will achieve an annual production capacity of 55,000 tons, and will rank among the first echelon of domestic BOPA film manufacturing.
Hezhong Sizhuang : Losing actual control over the two subsidiaries. The Canadian hemisphere and the US hemisphere will be out of the table.
Hezhong Sizhuang (002383) announced on the evening of September 26 that the company received a notice from the wholly-owned subsidiary Canadian hemisphere and the US hemisphere on September 24 that the Canadian hemisphere and the US hemisphere have completed the board of directors reorganization in accordance with the relevant agreements of the "National Security Agreement" signed with the US government. At present, the new board members have no entrusted relationship with the company. The company lost its actual control over the above two holding subsidiaries. The company no longer includes the Canadian hemisphere and the US hemisphere in the scope of consolidated financial statements. This matter is expected to have a certain impact on the company's consolidated financial statements in 2022.
Star Source Material : It plans to invest additional investment in European subsidiaries of no more than 872 million yuan
Star Source Material (300568) announced on the evening of September 26 that the company plans to invest additional investment in European subsidiaries. Among them, the additional investment in Xingyuan Materials (Europe) Co., Ltd. will not exceed RMB 192 million, which will be used for the expansion of the production of the second phase of the European Staryuan project, the coating production line and supporting equipment; the additional investment in Xingyuan Materials Senior Holdings (Europe) Co., Ltd. will not exceed RMB 680 million, which will be used for the purchase of land and factory buildings of its wholly-owned subsidiary Xingyuan Materials Asset Management Co., Ltd.
Xinya Electronics: plans to acquire Sino-German Cable and Kebao Optoelectronics for 560 million yuan
Xinya Electronics (605277) on the evening of September 26. The company plans to purchase 100% of Sino-German Cable and 30% of Kebao Optoelectronics for 560 million yuan through cash payment, with a total transaction amount of 560 million yuan. Before this restructuring, the company mainly engaged in fine electronic wire business. Through this transaction, the company will take advantage of the target company's advantages in sub-industry fields such as flame-retardant and fire-resistant cables, optoelectronic hybrid cables, industrial control automation cables, medical device cables, etc., to expand horizontally in the industrial chain and further integrate resources.
Ganfeng Lithium : It plans to increase its capital by US$962 million to its wholly-owned subsidiary Ganfeng International
Ganfeng Lithium (002460) announced on the evening of September 26 that the company plans to increase its capital by US$962 million to its wholly-owned subsidiary Ganfeng International; it will increase its capital by RMB300 million to Jiangxi Lingneng Lithium Co., Ltd. After the transaction is completed, the company will hold 35.29% of the equity of Lingneng Lithium.
mma Technology: The subsidiary and Huanfu Technology signed a product cooperation framework agreement
mma Technology (300698) announced on the evening of September 26 that the company's wholly-owned subsidiary Shanghai Youka recently signed a "Product Cooperation Framework Agreement" with Huanfu Technology and its affiliated "MNO Product Agreement" and its "Operation and Maintenance Service Agreement". The agreement stipulates that Huanfu Technology plans to purchase 10 million supporting software products and services from Shanghai Youka within five years.
Shutaishen : Compound polyethylene glycol (3350) electrolyte oral solution was approved for marketing
Shutaishen (300204) announced on the evening of September 26 that recently, the company received the "Drug Registration Certificate" approved and issued by the State Food and Drug Administration, marking that the company has obtained the qualification to produce and sell the drug in the domestic market. Compound polyethylene glycol (3350) electrolyte oral solution is another masterpiece of the company's continuous enrichment of constipation drug- polyethylene glycol product line. The indication is to treat chronic constipation .
Hongyun Co., Ltd.: The subsidiary signed a framework agreement for the procurement of high-purity ethylene oxide
Hongyun Co., Ltd. (002809) announced on the evening of September 26 that in order to ensure the stability of the supply of ethylene oxide, the main raw material of ethylene oxide and propylene oxide derivative project, the company's wholly-owned subsidiary Huizhou Hongyun recently signed a framework agreement on the supply and procurement of high-purity ethylene oxide with China Overseas Shell. The contract term is from September 26, 2022 to September 25, 2024 or the signing date of the "Supply and Procurement Agreement", which shall prevail.
Seiko Steel Structure : Signed a contract for 445 million yuan to undertake the stadium project for approximately RMB 445 million
Seiko Steel Structure (600496) announced on the evening of September 26 that the company recently signed the "Te Kaha (Canterbury Multi-Use Arena) Stadium Project Contract" with BESIX Watpac NZ (CMUA) Limited, which will be undertaken by the company in New Zealand's TE KAHA Stadium Project with the contract amount of RMB 108 million, equivalent to approximately RMB 445 million.
*ST Xifa: The subsidiary Lhasa Beer continues to suspend production due to the impact of the epidemic
*ST Xifa (000752) announced on the evening of September 26 that the company's subsidiary Lhasa Beer responded to the prevention and control of the new crown epidemic in Lhasa City, and has implemented suspension of work and work from home as required. The community where Lhasa Beer is located is currently a medium-risk area and has not received a notice from the government to resume work and production. In order to implement prevention and control requirements, Lhasa Beer continues to stop production. During the suspension of Lhasa Beer, the products were not out of stock or sold during the suspension of production, which is expected to have a significant adverse impact on the company's sales and profits in the third quarter.
Xinhua Insurance : Chairman Xu Zhibin resigned for work reasons
Xinhua Insurance (601336) announced on the evening of September 26 that Xu Zhibin resigned from the position of chairman, non-executive director, and chairman of the board of directors' strategic committee due to work reasons.
Gekewei: The subsidiary signed a loan contract of 3.5 billion yuan with financial institutions such as China Development Bank and other financial institutions
Gekewei (688728) announced on the evening of September 26 that the company's subsidiaryGeke Semiconductor (Shanghai) Co., Ltd. and the Shanghai Branch of the China Development Bank signed the "12-inch CIS Integrated Circuit Special Process R&D and Industrialization Project (Phase I) RMB Fund Syndicated Loan Contract", with a total loan amount of 3.5 billion yuan.
Huaqin Technology: Signed a sales contract for 248 million yuan of production project
Huaqin Technology (688281) announced on the evening of September 26 that the company recently signed a sales contract for the production project with a customer, with a total contract amount of 248 million yuan (including tax).
Priligy Pharmaceutical: Azithromycin for injection has been approved by the Singapore Health Sciences Authority for marketing
Priligy Pharmaceutical (300630) announced on the evening of September 26 that the company's registration application for azithromycin for injection has been approved by the Singapore Health Sciences Authority for marketing licensing, marking that the drug is qualified to sell in Singapore , and will have a positive impact on the company's expansion of the Singapore market.
Shan Gaohuaneng: It plans to jointly invest in the construction of biodiesel project with Shandong Shangneng
Shan Gaohuaneng (000803) announced on the evening of September 26 that the company plans to sign a cooperation agreement with Shandong Shangneng. The two parties plan to jointly invest in the construction of biodiesel project and establish a joint venture company Shan Gaohuaneng (Guangrao) New Energy Co., Ltd. with a registered capital of 300 million yuan, of which the company's subscribed capital was 153 million yuan, accounting for 51%. The project's designed production scale is 500,000 tons/year, that is, 100,000 tons/year ester-based biodiesel and 400,000 tons/hydrocarbon-based biodiesel, and is constructed in two phases.
Lisheng Sports: The subsidiary and Telecom Tianyi Digital Life signed a business cooperation framework agreement
Lisheng Sports (002858) announced on the evening of September 26 that the company's wholly-owned subsidiary Shanghai Yundongjia Sports Technology Co., Ltd. and China Telecom's wholly-owned subsidiary Tianyi Digital Life signed a "Business Cooperation Contract". The two parties will strengthen content cooperation based on Tianyi's high-definition value-added business platform, realize the supply of sports digital software and hardware products and services, provide users with safe and convenient one-stop intelligent digital life services, and work together to promote the construction of a basic platform for digital life.
Anzhong Co., Ltd.: The holding subsidiary plans to increase capital and expand shares to introduce strategic investment Ganfeng Lithium
Anzhong Co., Ltd. (002667) announced on the evening of September 26 that the company's controlling subsidiary (summit) company Jiangxi Lingneng Lithium Co., Ltd. plans to introduce strategic investor Ganfeng Lithium to increase its capital by 300 million yuan. After the capital increase, Ganfeng Lithium holds 35.29% of Lingneng Lithium.The company's wholly-owned subsidiary Youli Technology plans to increase its capital by 300 million yuan to Lingneng Lithium. After the capital increase, the equity of Lingneng Lithium will drop from 51% to 50.29%. The company is still the controlling shareholder of Lingneng Lithium.
Kangzhi Pharmaceutical: Cough-relieving Orange Red Granules obtained clinical trial license
Kangzhi Pharmaceutical (300086) announced on the evening of September 26 that the "Cough-relieving Orange Red Granules" submitted by the company to the State Food and Drug Administration received implied permission for clinical trials.
Hongwei Technology: It plans to invest 600 million yuan to build a discrete device project for automotive-grade power semiconductors
Hongwei Technology (688711) announced on the evening of September 26 that the company plans to invest 600 million yuan to build a discrete device production and research and development project for automotive-grade power semiconductors, with an estimated construction period of 3 years. After the project is completed, the company will form an annual production capacity of 8.4 million yuan of automotive-grade power semiconductor devices. The company plans to issue convertible bonds to to unspecified target to raise no more than 450 million yuan. The net fundraising amount after deducting issuance expenses will be used for the above-mentioned automotive-grade power semiconductor discrete device production and research and development projects (Phase I).
Jiaze New Energy: The wholly-owned subsidiary plans to invest 1.35 billion yuan in the industrial park project
Jiaze New Energy (601619) announced on the evening of September 26 that the company's wholly-owned subsidiary Jidong County Jiayi Wind Energy Boost Equipment Manufacturing Co., Ltd., Jidong County Jiayuan Wind Energy Boost Equipment Manufacturing Co., Ltd., and Liuzhou Jiaze New Energy Co., Ltd. plan to invest in the construction of the industrial park project. The project name is the Jidong County New Energy Equipment Manufacturing and New Energy Smart Operation Operation and Maintenance Park Project in Jixi City, Heilongjiang Province and the Zero Carbon New Energy Smart Equipment Industrial Park Project in the Northern Ecological New Area of Liuzhou City. The total planned investment of the above industrial park project is about 1.35 billion yuan. The company will invest funds in phases and batches depending on the progress of the project.
Jilin Aodong: Establish a medicinal material seed industry technology company; downward correction of convertible bond conversion price
Jilin Aodong (000623) announced on the evening of September 26 that it plans to invest 27 million yuan by its holding subsidiary Yanbian Pharmaceutical to establish a third-level subsidiary Jilin Aodong Medicinal Materials Seed Industry Technology Co., Ltd., which is mainly engaged in the research and development and sales of seeds and seeds of traditional Chinese medicinal materials; research and development and sales of pesticides and fertilizers for medicinal materials; processing and import and export trade of traditional Chinese medicinal materials. In addition, the conversion price of "Aodong Convertible Bond" will be revised down from 19.93 yuan per share to 14.5 yuan per share, and the adjustment effective date will be September 27.
Guangdong Hydropower: The 60MW agricultural and optical composite project in Bolian Town, Lingao County, Hainan Province is connected to the grid-connected power generation
Guangdong Hydropower (002060) announced on the evening of September 26 that the 60MW agricultural (vegetable basket project) optical composite project in Bolian Town, Lingao County, Hainan Province is connected to the grid-connected power generation. The grid-connected power generation of this project will have a certain effect on the company and Southeast Guangdong Hydropower's future operating performance. Up to now, the company has put into production and generates a total installed capacity of 1812.38MW of clean energy projects, including 313MW of hydropower, 723MW of wind power, and 776.38MW of photovoltaic power.
Sifang Optoelectronics: Received a designated notice for a famous European OEM project
Sifang Optoelectronics (688665) announced on the evening of September 26 that it received a designated notice for a famous European OEM project, confirming that the company provides it with customized development and supply services for fragrance generators. According to the above-mentioned customer forecast, the above-mentioned project target includes 3 vehicle model platforms, with an estimated life cycle of 5 years, 7 years and 8 years respectively, with a total amount of approximately 154 million yuan.
Huater Gas: It plans to invest 500 million yuan in electronic chemical production base project
Huater Gas (688268) announced on the evening of September 26 that the company plans to sign an agreement with the Management Committee of Rudong Coastal Economic Development Zone, Jiangsu Province to build an electronic chemical production base project. The total investment of the project is 500 million yuan. After completion, it can produce electronic gases such as 2,000 tons/year high-purity fluorocarbon gas, 1,000 tons/year high-purity carbon dioxide and 1,000 tons/year high-purity nitrous oxide, etc., and separate 200,000 Nm³/year liquid helium, 1,600 tons/year ethylene oxide, 15,000 tons/year liquid ammonia (including high-purity) and 1 million bottles/year ordinary industrial gases, and store and operate various electronic chemicals.
Jiangsu Wuzhong: Acetylcysteine solution for inhalation is approved for marketing
Jiangsu Wuzhong (600200) announced on the evening of September 26 that the wholly-owned subsidiary Suzhou Pharmaceutical Factory has received a drug registration certificate approved and issued by the State Food and Drug Administration. This product is used to treat respiratory infections characterized by excessive thick mucus secretions, such as acute bronchitis, chronic bronchitis, etc.
Kelu Electronics: It plans to transfer 100% of the equity of Huailai Zhongshang New Energy Company
Kelu Electronics (002121) announced on the evening of September 26 that the company's wholly-owned subsidiary Hebei Fenglong Photovoltaic Power Generation Co., Ltd. plans to transfer 100% of the equity of Huailai Zhongshang New Energy Technology Co., Ltd., with a listing base price of 40.7 million yuan. This equity transfer is conducive to the company's revitalization of funds and focusing on its core business.
[Suspension and resumption of trading]
Tai'antang: The company's stocks were subject to other risk warnings on September 28, and suspended trading for one day on the 27th
Tai'antang (002433) announced on the evening of September 26 that the company's stocks will be suspended for one day from the opening of the market on September 27, and resume trading from the opening of the market on September 28. After the resumption of trading, the company's stocks were subject to other risk warnings. The stock abbreviation became "ST Tai'an", with a daily increase and decline limit of 5%.
This article is from the financial industry
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-